Article R5121-161 of the French Public Health Code
November 2, 2023
The doctor, dental surgeon, midwife, pharmacist or nurse shall immediately report any adverse reaction suspected of being due to a medicinal product or to a product mentioned in article R. 5121-150 of which he is aware to the regional pharmacovigilance centre. Other healthcare professionals, patients and approved patient associations may report any adverse reaction suspected of being due to a medicinal product or a product mentioned in Article R. 5121-150…
